Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

California Trim Clinic vs Eve

California Trim Clinic
Graded #470

Lower grade

vs+13.099999999999994
Eve
Graded #189

Higher grade

The verdict

Eve takes it — 66.3/100 to 53.2/100.

Eve grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEve +10
45
55
Dose & formulationEve +48
40
88
Clinical oversightEve +3
76
79
Labs & monitoringCalifornia Trim Clinic +11
63
52
FulfillmentEve +3
64
67
Contract termsEve +21
20
41
California Trim Clinic · left barEve · right bar

The numbers

MetricCalifornia Trim ClinicEve
WeighScore53.2/10066.3/100
GradeCC
Scorecard rank#470#189
SemaglutideNot disclosed$195/mo (compounded)
TirzepatideNot disclosed$195/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
California Trim Clinic

Graded #470 · C

Strengths

  • Women's microdosing program specifically designed for perimenopause/menopause weight management
  • 100% virtual nationwide telehealth; medications shipped discreetly to patients' homes
  • 503A state-licensed compounding pharmacies with patient-specific prescription preparation
  • $199 initial plan covers doctor consultation, telehealth setup, and full onboarding
  • Ongoing 3-month treatment plans include compounded medication and licensed provider check-ins

Where it loses points

  • Ongoing medication pricing not publicly disclosed — revealed only after $199 intake and provider approval
  • No LegitScript certification or any other third-party accreditation visible on the site
  • No physician names or clinical leadership disclosed publicly
  • States served listed as 'nationwide' for telehealth but no state-by-state list published
  • Microdose framing uses sub-clinical doses — potentially lower weight-loss efficacy than standard GLP-1 protocols
Eve

Graded #189 · C

Strengths

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • LegitScript Certified with a verifiable ID
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

Where it loses points

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard